Abstract
Prostate cancer is now the most commonly diagnosed cancer amongst men in France despite the absence of a generalized screening program. Prostate-specific antigen (PSA) level can be used as a screening test. We report the case of an 86-year-old patient, whose metastatic prostate cancer was diagnosed on an unusually high PSA level (over 5000µg/L), without urologic signs. The diagnostic was then confirmed by a thoracicabdominal-pelvic CT scan, which found diffuse metastases, before hormonal therapy started.
Highlights
In 2015 in France, 50,430 incident cases of prostate cancer were identified
We report the case of an 86-year-old patient, whose metastatic prostate cancer was diagnosed on an unusually high Prostate-specific antigen (PSA) level, without urologic signs
In 1994, it was shown that combining rectal examination and PSA level increased the rate of diagnosis at an early stage to 70-85%, compared to 30% when detection was based on rectal examination only [3]
Summary
In 2015 in France, 50,430 incident cases of prostate cancer were identified. It is the most commonly diagnosed cancer amongst men. With more than 8,500 attributable deaths, prostate cancer is the third most deadly cancer amongst men, it is one with a good prognosis. The net survival at 5 years is equal to 93% at all stages [1]. There is no generalized prostate cancer screening program in France. Nonaggressive treatments exist, which explain the importance of an early diagnostic to limit the progression
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
